Trexima – sooner rather than later?

There is a lot of hope that the drug Trexima will provide a treatment that is unique to everything else on the market.  In spite of the fact that it is really a combination of drugs already available, it looks like the combination and delivery that Trexima has makes it greater than the sum of its parts.  As Trexima proves itself, it’s likely other similar drugs will become available afterwards.  But Pozen, Inc has been having a terrible time actually getting it on the market.

Just when it looked ready for release, the American FDA said they weren’t satisfied with the safety information.  So now what?  More trials?  More changes?  These things can take years.

Well, it looks like it may be sooner rather than later.  Yesterday Pozen announced that it would provide the needed information by the end of the year.  This seems to indicate that more trials aren’t needed, just an organization of the data that is already available.  If all goes well, the drug may yet be available before the end of 2007.  Here’s hoping they can get everything worked out.  But it’s probably worth it to check out other options in the mean time – not many of us will be holding out breath.